Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Gastric Cancer

Free Subscription 01.12.2025 5 BMC Cancer 3 BMC Gastroenterol 2 Endoscopy 2 Eur J Cancer 3 Eur J Surg Oncol 1 Gastroenterology 1 J Cancer Res Clin Oncol 1 J Gastroenterol Hepatol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. YI S, Cai Q, Dong W, Lan W, et al
   Development and validation of a simple prediction risk score for predicting risk of gastric cancer in outpatient department.
   BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15294.
   PubMed        
   
   
2. SAFI MH, Hui Z, Xiaoyong W, Bingtuan L, et al
   Endoscopic submucosal dissection: a safe alternative to surgical intervention for young patients under 45 years of age with early gastric cancer. ESD vs. surgery in young EGC patients.
   BMC Cancer. 2025 Nov 22. doi: 10.1186/s12885-025-15293.
   PubMed         Abstract available
   
   
3. ZHU M, Hu Q, Lu Y, Xu Q, et al
   Quercetin inhibits gastric cancer cell proliferation and migration and is associated with the suppression of the IDO1-Kynurenine-AhR axis.
   BMC Cancer. 2025 Nov 25. doi: 10.1186/s12885-025-15308.
   PubMed         Abstract available
   
   
4. TRIEMSTRA L, Spruijt SWJM, Vriens D, Vegt E, et al
   [(18)F]F-FAPI PET/CT and LAparoscopy in STagIng advanced gastric Cancer: a multicenter prospective study (PLASTIC-3 study).
   BMC Cancer. 2025 Nov 27. doi: 10.1186/s12885-025-15347.
   PubMed         Abstract available
   
   
5. MOURDI N, Wu Y, Su Y, Zhao Y, et al
   The role of indocyanine green in the intraoperative navigation of gastric cancer surgery: a systematic review and meta-analysis.
   BMC Cancer. 2025 Nov 26. doi: 10.1186/s12885-025-15306.
   PubMed        
   
   

   
   BMC Gastroenterol

6. ZHOU Q, Yan R, Wu X, Guo H, et al
   Effects of Helicobacter pylori infection on gastric cancer, obesity and esophageal diseases: a systematic review and meta-analysis.
   BMC Gastroenterol. 2025;25:839.
   PubMed         Abstract available
   
   
7. SHEN DY, Li ZY, Xia WB, Li D, et al
   Long-term prognostic value of postoperative C-reactive protein in gastric cancer patients: a systematic review and meta-analysis.
   BMC Gastroenterol. 2025 Nov 26. doi: 10.1186/s12876-025-04481.
   PubMed         Abstract available
   
   
8. IKEGAME K, Omori H, Hada M, Watanabe H, et al
   Analysis of perioperative chemotherapy-mediated genomic changes in gastric cancer.
   BMC Gastroenterol. 2025;25:832.
   PubMed         Abstract available
   
   

   
   Endoscopy

9. FONTES F, Kapteijn NEA, Hassan C, Deane C, et al
   Adherence to clinical practice guidelines for Management of epithelial precancerous conditions and lesions in the stomach in Europe.
   Endoscopy. 2025;57:1338-1347.
   PubMed         Abstract available
   
   
10. TURKOT MH, Zaborowska M, Pilonis ND, Lenarcik M, et al
    Malignant progression and recurrence rates following endoscopic treatment of gastric hyperplastic polyps.
    Endoscopy. 2025;57:1348-1354.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

11. LOWERY MA, Wyrwicz LS, Oh DY, Shiu KK, et al
    First-line pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma: Health-related quality of life from the randomized phase III KEYNOTE-859 trial.
    Eur J Cancer. 2025;231:115807.
    PubMed         Abstract available
    
    
12. CRISTARELLA E, Ambrosini M, Di Maio M, Lonardi S, et al
    Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trial.
    Eur J Cancer. 2025;231:116060.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

13. VELAYUDHAM GK, Shankar AS, Fox SJ, Bundred J, et al
    Impact of readmission location on survival after oesophagectomy and gastrectomy.
    Eur J Surg Oncol. 2025;51:110470.
    PubMed         Abstract available
    
    
14. BARTIN MK, Dogan I, Aslan F
    Surgical treatment in synchronous oesophageal cancers - A systematic review on survival outcomes.
    Eur J Surg Oncol. 2025;51:110480.
    PubMed         Abstract available
    
    
15. BAKHTIAR M, Razi S, Ahmed R, Mahnoor M, et al
    Efficacy and safety of intraperitoneal paclitaxel-based regimens in patients with gastric cancer and peritoneal metastasis: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2025;52:111299.
    PubMed         Abstract available
    
    

    
    Gastroenterology

16. HE J, Papa G, Azizi F, Kirsche L, et al
    Gastric Organoid-Based Ectopic and Orthotopic In Vivo CRISPR Screening for Tumor Suppressors in Gastric Cancer.
    Gastroenterology. 2025 Nov 25:S0016-5085(25)05992.
    PubMed         Abstract available
    
    

    
    J Cancer Res Clin Oncol

17. LIU Y, Jia L, Yang L, Ning Z, et al
    Research progress on ferroptosis in drug resistance and therapy of gastric cancer.
    J Cancer Res Clin Oncol. 2025;152:1.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

18. DENG X, Hu Y, Yang X, Luo X, et al
    FTO Upregulates GLG1 Expression via m(6)A Methylation Modification to Facilitate Gastric Cancer Cell Migration and Invasion.
    J Gastroenterol Hepatol. 2025 Nov 24. doi: 10.1111/jgh.70170.
    PubMed         Abstract available
    
    

    
    PLoS One

19. CHEN Y, Feng P, Lou X, Wang H, et al
    Weifuchun alleviates MNNG-induced chronic atrophic gastritis by improving the gastric and intestinal microbiota homeostasis.
    PLoS One. 2025;20:e0333375.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.